Latest news
Loading news…
Arsia Therapeutics
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Waltham, Massachusetts, United States Founded 2013 11-50 employees For Profit
Arsia Therapeutics’ mission is to improve access to these life-saving drugs.
Arsia Therapeutics was acquired by Eagle Pharmaceuticals in 2016 for $78M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Patents
4
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 21
- Patents granted
- 4
- Trademarks
- 0
- Top patent class
- Medical Or Veterinary Science; Hygiene
- IT spend
- $9M
Company Info
- Founded
- 2013
- Employees
- 11-50
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- News articles
- 1
- HQ
- Waltham, Massachusetts, United States
- Region
- Greater Boston Area, East Coast, New England
- Diversity spotlight
- Women Led
- Exit date
- Nov 11, 2016
Signals & Scores
- Heat score
- Medium
- Trend (7d)
- -0.2
- Trend (30d)
- -0.5
- Trend (90d)
- 8.1
Key People at Arsia Therapeutics
Vice President of Research & Development
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Arsia Therapeutics
Loading news…
FAQs about Arsia Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.